Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer
Kosei Hasegawa, Takafumi Nakamura, Mary Harvey, et al.
Cancer Gene Therapy
|
January 25, 2019
Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging
Rianna Vandergaast, Sarawut Khongwichit, Huailei Jiang, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma
Boris Blechacz, Patrick L Splinter, Suzanne Greiner, et al.
Gynecologic Oncology
|
January 18, 2014
Oncolytic vaccinia virotherapy for endometrial cancer
Yu-Ping Liu, Jiahu Wang, Victoria A Avanzato, et al.
Journal of Hepatology
|
July 23, 2013
Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth
Hooi-Tin Ong, Mark J Federspiel, Chang M Guo, et al.
Gynecologic Oncology
|
November 20, 2013
Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer
Yu-Ping Liu, Michael B Steele, Lukkana Suksanpaisan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 15, 2007
Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas
Georgia Paraskevakou, Cory Allen, Takafumi Nakamura, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 16, 2012
Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus
Ianko D Iankov, Cory Allen, Mark J Federspiel, et al.
American Journal of Hematology
|
June 10, 2009
Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma
Kah-Whye Peng, Ahmet Dogan, Julie Vrana, et al.
Blood
|
November 8, 2003
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
David Dingli, Kah-Whye Peng, Mary E Harvey, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer
Kosei Hasegawa, Takafumi Nakamura, Mary Harvey, et al.
Cancer Gene Therapy
|
January 25, 2019
Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging
Rianna Vandergaast, Sarawut Khongwichit, Huailei Jiang, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma
Boris Blechacz, Patrick L Splinter, Suzanne Greiner, et al.
Gynecologic Oncology
|
January 18, 2014
Oncolytic vaccinia virotherapy for endometrial cancer
Yu-Ping Liu, Jiahu Wang, Victoria A Avanzato, et al.
Journal of Hepatology
|
July 23, 2013
Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth
Hooi-Tin Ong, Mark J Federspiel, Chang M Guo, et al.
Gynecologic Oncology
|
November 20, 2013
Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer
Yu-Ping Liu, Michael B Steele, Lukkana Suksanpaisan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 15, 2007
Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas
Georgia Paraskevakou, Cory Allen, Takafumi Nakamura, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 16, 2012
Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus
Ianko D Iankov, Cory Allen, Mark J Federspiel, et al.
American Journal of Hematology
|
June 10, 2009
Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma
Kah-Whye Peng, Ahmet Dogan, Julie Vrana, et al.
Blood
|
November 8, 2003
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
David Dingli, Kah-Whye Peng, Mary E Harvey, et al.
Page
of 12